OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
4.910
+0.160 (3.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
OptimizeRx Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$8.25
Upside
+68.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Hold Initiates $5.5 | Hold | Initiates | $5.5 | +12.02% | Dec 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $16 → $8 | Buy | Maintains | $16 → $8 | +62.93% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $7 | Buy | Maintains | $14 → $7 | +42.57% | Nov 14, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 → $16 | Strong Buy | Reiterates | $20 → $16 | +225.87% | Nov 14, 2024 |
| Stifel | Stifel | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +62.93% | Nov 14, 2024 |
| Barclays | Barclays | Hold Maintains $11 → $5 | Hold | Maintains | $11 → $5 | +1.83% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $14 | Buy | Maintains | $17 → $14 | +185.13% | Aug 16, 2024 |
| Barclays | Barclays | Hold Maintains $15 → $11 | Hold | Maintains | $15 → $11 | +124.03% | Aug 12, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +225.87% | Jun 24, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +225.87% | Jun 21, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +225.87% | May 15, 2024 |
| Stifel | Stifel | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +164.77% | May 15, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +205.50% | Apr 16, 2024 |
| JMP Securities | JMP Securities | Buy Initiates $15 | Buy | Initiates | $15 | +205.50% | Apr 4, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +246.23% | Apr 1, 2024 |
| Stifel | Stifel | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +164.77% | Apr 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.